Monitoring foreign gene expression by a human adenovirus-based vector using the firefly luciferase gene as a reporter - PubMed (original) (raw)
Monitoring foreign gene expression by a human adenovirus-based vector using the firefly luciferase gene as a reporter
S K Mittal et al. Virus Res. 1993 Apr.
Abstract
We have constructed a helper-independent adenovirus type 5-luciferase recombinant (Ad5-Luc 3) containing the firefly luciferase gene flanked by simian virus 40 (SV40) regulatory sequences inserted in the early region 3 (E3) of the Ad5 genome. Expression of luciferase in cells infected with Ad5-Luc3 was relatively efficient. In HeLa cells approximately 20 micrograms luciferase per 10(6) cells was made by 36 h post-infection and a 62 kilo-Dalton (kDa) luciferase band was clearly visible in a [35S]methionine-labeled Ad5-Luc 3-infected cell extract analyzed directly by sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE). The results of experiments in which cultured cells were infected with Ad5-Luc 3 in the presence or absence of 1-beta-D-arabinofuranosyl cytosine (AraC) showed that the majority of luciferase expression was dependent on viral DNA replication. This suggested that the enzyme was probably translated primarily from mRNA derived from transcripts expressed from the major late promoter of Ad5. An anti-luciferase antibody was raised in a rabbit and used to further characterize the luciferase expressed in HeLa cells infected with Ad5-Luc 3 by immunoprecipitations and Western blot analyses. The half-life of luciferase expressed in HeLa cells infected with Ad5-Luc 3 was calculated to be approximately 6-8 h by pulse chase analysis. Luciferase is likely to be a useful marker for monitoring virus dissemination and gene expression in experimental animals because assays for enzymatic activity are extremely sensitive and backgrounds are low in all tissues. In mice inoculated intraperitoneally (i.p.) with Ad5-Luc 3, luciferase activity was detected in the liver, spleen, kidney, and lung. A single i.p. inoculation of mice with Ad5-Luc 3 was sufficient to raise anti-luciferase antibody and Ad5 neutralizing antibody which persisted for at least 8 weeks. Even in the presence of circulating anti-luciferase and Ad5 neutralizing antibodies, luciferase activity could be detected in the livers, spleens, and kidneys of mice inoculated i.p. a second time with Ad5-Luc 3.
Similar articles
- Foreign gene expression by human adenovirus type 5-based vectors studied using firefly luciferase and bacterial beta-galactosidase genes as reporters.
Mittal SK, Bett AJ, Prevec L, Graham FL. Mittal SK, et al. Virology. 1995 Jun 20;210(1):226-30. doi: 10.1006/viro.1995.1337. Virology. 1995. PMID: 7793076 - Development of a bovine adenovirus type 3-based expression vector.
Mittal SK, Prevec L, Graham FL, Babiuk LA. Mittal SK, et al. J Gen Virol. 1995 Jan;76 ( Pt 1):93-102. doi: 10.1099/0022-1317-76-1-93. J Gen Virol. 1995. PMID: 7844546 - Effects of pre-existing anti-adenovirus antibodies on transgene expression levels and therapeutic efficacies of arming oncolytic adenovirus.
Ono R, Nishimae F, Wakida T, Sakurai F, Mizuguchi H. Ono R, et al. Sci Rep. 2022 Dec 13;12(1):21560. doi: 10.1038/s41598-022-26030-3. Sci Rep. 2022. PMID: 36513733 Free PMC article. - The molecular basis of adenovirus pathogenesis.
Ginsberg HS, Prince GA. Ginsberg HS, et al. Infect Agents Dis. 1994 Feb;3(1):1-8. Infect Agents Dis. 1994. PMID: 7952924 Review. - The life and times of adenoviruses.
Ginsberg HS. Ginsberg HS. Adv Virus Res. 1999;54:1-13. doi: 10.1016/s0065-3527(08)60363-2. Adv Virus Res. 1999. PMID: 10547672 Review.
Cited by
- Cancer immunotherapies: A hope for the uncurable?
Hamdan F, Cerullo V. Hamdan F, et al. Front Mol Med. 2023 Feb 17;3:1140977. doi: 10.3389/fmmed.2023.1140977. eCollection 2023. Front Mol Med. 2023. PMID: 39086690 Free PMC article. Review. - Evaluation of two inoculation routes of an adenovirus-mediated viral protein inhibitor in a Crimean-Congo hemorrhagic fever mouse model.
Scholte FEM, Spengler JR, Welch SR, Harmon JR, Coleman-McCray JD, Davies KA, Pegan SD, Montgomery JM, Spiropoulou CF, Bergeron É. Scholte FEM, et al. Virus Res. 2024 Jul;345:199398. doi: 10.1016/j.virusres.2024.199398. Epub 2024 May 20. Virus Res. 2024. PMID: 38754786 Free PMC article. - Expanding the adenovirus toolbox: reporter viruses for studying the dynamics of human adenovirus replication.
King CR, Dodge MJ, MacNeil KM, Tessier TM, Mymryk JS, Mehle A. King CR, et al. J Virol. 2024 May 14;98(5):e0020724. doi: 10.1128/jvi.00207-24. Epub 2024 Apr 19. J Virol. 2024. PMID: 38639487 Free PMC article. - Fragile X-Related Protein FXR1 Controls Human Adenovirus Capsid mRNA Metabolism.
Hajikhezri Z, Kaira Y, Schubert E, Darweesh M, Svensson C, Akusjärvi G, Punga T. Hajikhezri Z, et al. J Virol. 2023 Feb 28;97(2):e0153922. doi: 10.1128/jvi.01539-22. Epub 2023 Feb 7. J Virol. 2023. PMID: 36749074 Free PMC article. - Effect of Transgene Location, Transcriptional Control Elements and Transgene Features in Armed Oncolytic Adenoviruses.
Farrera-Sal M, Fillat C, Alemany R. Farrera-Sal M, et al. Cancers (Basel). 2020 Apr 23;12(4):1034. doi: 10.3390/cancers12041034. Cancers (Basel). 2020. PMID: 32340119 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources